South African Billionaire Tops Los Angeles Wealth Rankings.

South African-born physician and biotech entrepreneur Patrick Soon-Shiong has risen to the top of Los Angeles’ wealth rankings.

His estimated net worth now stands at $8.4 billion, according to 2026 valuations. He now leads one of the most competitive billionaire landscapes in the United States.

He built his fortune after leaving South Africa and expanding his medical and biotech career across North America.

He first trained as a surgeon and later moved into biotechnology innovation. That shift changed his financial trajectory and positioned him among the most influential medical entrepreneurs in the world.

Soon-Shiong created much of his wealth through biotech ventures such as APP Pharmaceuticals and Abraxis BioScience. He also developed Abraxane, a widely used cancer treatment that strengthened his global reputation in oncology innovation.

These breakthroughs helped him scale rapidly in the US healthcare market.

He later sold APP Pharmaceuticals in 2008 and Abraxis BioScience in 2010 for a combined $9.1 billion. That deal became a defining moment in his financial rise. It also cemented his place among the world’s elite biotech founders.

His success story reflects a broader South African pattern. Entrepreneurs like Elon Musk, Mark Shuttleworth, and Roelof Botha also built global fortunes outside the country. South Africa continues to produce high-impact talent even as many founders scale abroad.

Despite economic pressure, South Africa still dominates Africa’s wealth landscape. Reports from the Africa Wealth Report 2025 show over 41,100 dollar millionaires in the country. It also records more than 100 centi-millionaires and several billionaires, which places South Africa far ahead of other African markets.

Johannesburg and Cape Town remain key financial engines. They support strong capital markets, advanced legal systems, and deep investment ecosystems. However, many high-growth entrepreneurs still expand globally to unlock larger opportunities.

Soon-Shiong also maintained ties with South Africa’s healthcare sector. In 2021, he joined government-led efforts to launch NantSA, a biotech initiative focused on vaccine development and pharmaceutical production. The project later expanded into Cape Town, strengthening Africa’s life sciences ecosystem.

This growing link between diaspora billionaires and local innovation ecosystems signals a shift. South Africa is no longer only exporting talent. It is also attracting biotech investment back into the continent.

For investors, the message is clear. Wealth creation now depends on global mobility, strong science ecosystems, and scalable innovation infrastructure. South Africa continues to supply talent, but global markets often unlock the biggest financial outcomes.